Holen Sie sich die Stockscreener-App
0.509
18.43%
0.0792
Handel nachbörslich:
.50
-0.009
-1.77%
Nexalin Technology Inc Aktie (NXL) Neueste Nachrichten
Nexalin Technology Advances Global Clinical Strategy for Alzheimer’s Treatment Following Key FDA Meetings - Quiver Quantitative
After FDA and China meetings, Nexalin reshapes Alzheimer’s study - Stock Titan
Nexalin Hosts Live Investor Webinar and Q&A - National Today
Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21 - Yahoo Finance
Macro Review: Whats next for Nexalin Technology Inc Equity Warrant stock2026 Decliners & Fast Gain Stock Trading Tips - baoquankhu1.vn
Targets Report: Why is Nexalin Technology Inc Equity Warrant stock going upQuarterly Profit Summary & Daily Growth Stock Investment Tips - baoquankhu1.vn
Hedge Fund Moves: Is Nexalin Technology Inc still a buy after recent gains2026 Retail Activity & Low Drawdown Trading Strategies - baoquankhu1.vn
EXCLUSIVE: Nexalin Study Flags Reduced Self-Injury In Adolescents Using Brain Stimulation Device - Sahm
Hedge Fund Moves: What analysts say about Nexalin Technology Inc stock2026 Price Swings & Daily Price Action Insights - baoquankhu1.vn
Profit Review: Whats next for Nexalin Technology Inc Equity Warrant stock2026 Short Interest & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents - Bitget
Nexalin Technology, Inc. Reports Significant Reductions in Self-Injury Behaviors and Depressive Symptoms in BMC Psychiatry Publication on DIFS Approach - Quiver Quantitative
Nexalin teen pilot finds noninvasive brain stimulation cut self-harm - Stock Titan
Levels Update: Will Nexalin Technology Inc benefit from geopolitical trends2026 EndofYear Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
NXL SEC FilingsNexalin Tech 10-K, 10-Q, 8-K Forms - Stock Titan
Maxim Group Maintains Nexalin Technology(NXL.US) With Buy Rating, Cuts Target Price to $2 - Moomoo
Aug Gainers: Does Nexalin Technology Inc stock benefit from AI growth2026 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Treasury Yields: Is Nexalin Technology Inc Equity Warrant stock a good dividend stock2026 Setups & Growth Oriented Trade Recommendations - baoquankhu1.vn
Trade Recap: Why is Nexalin Technology Inc Equity Warrant stock going up2026 Technical Overview & Real-Time Buy Zone Alerts - baoquankhu1.vn
NXL PE Ratio & Valuation, Is NXL Overvalued - Intellectia AI
Nexalin Technology (NXL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Merger Talk: Can Nexalin Technology Inc Equity Warrant be recession proofTreasury Yields & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Wall Street Recap: Will Nexalin Technology Inc Equity Warrant outperform during market rallies2026 Highlights & Weekly High Return Opportunities - baoquankhu1.vn
Breakout Zone: Whats Nexalin Technology Inc Equity Warrants historical return2026 Market Sentiment & Risk Managed Investment Signals - baoquankhu1.vn
Fund Flows: Is Nexalin Technology Inc a turnaround story2026 Risk Factors & Fast Gain Swing Alerts - baoquankhu1.vn
Growth Value: Is Nexalin Technology Inc Equity Warrant subject to activist investor interestQuarterly Trade Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Nexalin Technology Inc reports results for the quarter ended December 31Earnings Summary - tradingview.com
Nexalin Technology (NASDAQ: NXL) outlines losses, trials and U.S. FDA pathway - Stock Titan
Nexalin Technology 10-K: Revenue $0.302M, Net loss $(8.222M) - TradingView
Trading Action: Can Nexalin Technology Inc Equity Warrant outperform in the next rally2026 WrapUp & Accurate Intraday Trading Signals - baoquankhu1.vn
Inflation Data: Can Nexalin Technology Inc Equity Warrant outperform in the next rallyQuarterly Risk Review & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Stock Market Recap: What is Nexalin Technology Inc Equity Warrants 5 year growth outlookTrade Risk Summary & Capital Protection Trading Alerts - baoquankhu1.vn
If You Invested $1,000 in Nexalin Tech (NXL) - Stock Titan
Volatility Watch: Whats next for Nexalin Technology Inc Equity Warrant stock2026 AllTime Highs & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
NXL Should I Buy - Intellectia AI
Earnings Miss: Is Nexalin Technology Inc Equity Warrant subject to activist investor interestExit Point & Technical Pattern Alert System - baoquankhu1.vn
Breakout Zone: What are analysts price targets for Nexalin Technology Inc Equity WarrantEarnings Miss & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Revenue Check: Is Nexalin Technology Inc showing insider buying2026 Technical Patterns & Accurate Buy Signal Alerts - baoquankhu1.vn
Portfolio Shifts: Can Nexalin Technology Inc keep up with sector leadersOil Prices & Free Accurate Trade Setup Notifications - baoquankhu1.vn
S P Trends: Does Nexalin Technology Inc have consistent dividend growthEarnings Risk Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Market Catalysts: Why is Nexalin Technology Inc Equity Warrant stock going up2026 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Smart Money: What is Nexalin Technology Inc Equity Warrants 5 year growth outlookWeekly Trade Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Nexalin Technology Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Short Squeeze: What is Nexalin Technology Inc Equity Warrants 5 year growth outlookWeekly Trade Summary & Fast Moving Market Watchlists - baoquankhu1.vn
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Green Bay Press-Gazette
Short Squeeze: Will Nexalin Technology Inc. stock deliver shareholder valuePortfolio Risk Report & Precise Swing Trade Entry Alerts - Naître et grandir
Exit Recap: Can Nexalin Technology Inc. deliver consistent dividends2025 Market WrapUp & Long Hold Capital Preservation Tips - baoquankhu1.vn
Ideas Watch: Does Nexalin Technology Inc have consistent dividend growthQuarterly Investment Review & AI Based Trade Execution Alerts - baoquankhu1.vn
Market Catalysts: Whats next for Nexalin Technology Inc Equity Warrant stock2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
NXL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Hedge Fund Bets: What are analysts price targets for Nexalin Technology Inc Equity Warrant2025 Market WrapUp & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Nexalin Advances Pivotal HALO Clarity Trial for Insomnia - The Globe and Mail
Nexalin Announces 150-Patient Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission - TradingView
Nexalin (Nasdaq: NXL) advances pivotal HALO Clarity insomnia trial toward FDA de novo bid - Stock Titan
Nasdaq Moves: Can Nexalin Technology Inc Equity Warrant continue delivering strong returns2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Nexalin Launches Pivotal HALO Clarity Trial To Support Planned FDA Submission For Insomnia - Nasdaq
Nexalin announces pivotal Halo(TM) Clarity trial - marketscreener.com
Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market - The Manila Times
Drug-free insomnia device trial targets 30 million adults - Stock Titan
EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia - Bitget
Nexalin Announces Pivotal HALO™ Clarity Trial to Support - GlobeNewswire
Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders - Bitget
Nexalin Technology, Inc. Applauds Bipartisan Congressional Support for Deep Brain Neurostimulation Research and Expanding Access for Veterans - Quiver Quantitative
Congress boosts brain stimulation research for veterans, with Nexalin involved - Stock Titan
NXLNexalin Tech Latest Stock News & Market Updates - Stock Titan
2.40%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):